Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This editorial highlights findings that TGF-β1 promotes endothelial-mesenchymal transition in AF, offering new insights into the cellular origins of atrial fibroblasts and potential therapeutic targets for fibrosis.
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, with an unmet therapeutic need. Fibrotic remodeling, in which collagen-producing atrial fibroblasts play a crucial role, substantially contributes to arrhythmia promotion and progression. In this issue of the JCI, Lai, Tsai, and co-authors reveal that TGF-β1 promoted endothelial-mesenchymal transition during AF and put forward the notion that, in the adult heart, atrial fibroblasts can originate from different cellular sources. These important findings extend our understanding of the origin, biology, and function of fibroblasts and offer possibilities for therapeutic targeting of fibrosis in AF.
No takes yet. Share an insight, caveat, or question.
Saljic et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: